Affecting an estimated 332 million worldwide, depression represents a major public health challenge of our era (World Health Organisation, 2025). Despite widely implemented first-line treatments such as cognitive behavioural therapy (CBT) and antidepressant medication (NICE, 2022), only 30-40% of patients fully recover. This burdensome reality leaves the majority cycling through care services with ongoing impairment, repeated referrals, little sense of...
A new study suggests that adolescents who experience more negative life events are more likely to develop depressive symptoms, with girls showing particularly...
Over the last two decades, research into psychedelic and cannabinoid-based treatments for mental health disorders has rapidly expanded.
Classical psychedelics (LSD, psilocybin and DMT)...